Beijing Beilu Pharmaceutical Co Ltd (300016) - Pharmaceuticals & Healthcare - De

Posted by Reports and Markets on August 23rd, 2017

Get Sample report @ https://www.reportsandmarkets.com/sample-request/1541092-beijing-beilu-pharmaceutical-co-ltd-300016-alliances-profile-1541042

Summary

Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company’s product portfolio comprises contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its contrast media agents are used in angiography, arteriography, intravenous urography and computerized tomography scanning, among others. Beijing BeiLu’s medicinal products are used for the treatment of type 2 diabetes, psychological disorders and neurological disorders. It also offers products such as lohexol injection, gadopentetate dimeglumine injection and jiuwei zhenxin granules, among others. The company operates in Miyun County Industrial Development Zone, China. Beijing BeiLu is headquartered in Beijing, China.

Beijing Beilu Pharmaceutical Co Ltd (300016) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. 
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. 
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. 
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. 
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. 
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. 
- Business Description - A brief description of the company's operations. 
- Key Employees - A list of the key executives of the company. 
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. 
- Key Competitors - A list of the key competitors of the company. 
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements 
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy 
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company 
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. 
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company 
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research 
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Get Access report @ https://www.reportsandmarkets.com/reports/1541092-beijing-beilu-pharmaceutical-co-ltd-300016-alliances-profile-1541042

Table of Content

Table of Contents 3 
List of Tables 4 
List of Figures 4 
Beijing Beilu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5 
Beijing Beilu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6 
Beijing Beilu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7 
Beijing Beilu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8 
Beijing Beilu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9 
Beijing Beilu Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10 
Venture Financing 10 
Geneseeq Technology Raises USD9 Million in Series B Financing 10 
Equity Offering 11 
Beijing Beilu Pharma Plans to Raise up to USD40.7 Million in Private Placement of Shares 11
Acquisition 12 
Beijing BeiLu Pharma to Acquire 20% Stake in Geneseeq for USD4.8 Million 12 
Beijing Beilu Pharmaceutical Co Ltd - Key Competitors 13 
Beijing Beilu Pharmaceutical Co Ltd - Key Employees 14 
Beijing Beilu Pharmaceutical Co Ltd - Locations And Subsidiaries 15 
Head Office 15 
Appendix 16 
Methodology 16 
About GlobalData 16 
Contact Us 16 
Disclaimer 16

Contact Us

Office No: 206 Empress Mill Society

Shree Nagar, Nagpur - 440015

Maharashtra India

Ph: +44-020-3286-9338 (UK)

+1-214-377-1121 (US)

info@reportsandmarkets.com

https://www.reportsandmarkets.com/